CBS 2019
CBSMD教育中心
中 文

Other Relevant Articles

Abstract

Recommended Article

Randomized Trial Evaluating Percutaneous Coronary Intervention for the Treatment of Chronic Total Occlusion: The DECISION-CTO Trial Residual Inflammatory Risk in Patients With Low LDL Cholesterol Levels Undergoing Percutaneous Coronary Intervention Cholesterol-Lowering Agents Advances in Coronary No-Reflow Phenomenon-a Contemporary Review Management of No-Reflow Phenomenon in the Catheterization Laboratory Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association Causes of Mortality After Percutaneous Coronary Intervention: Insights From the VA Clinical Assessment, Reporting, and Tracking Program Cardiac Sympathetic Denervation for Refractory Ventricular Arrhythmias

Guideline2013 Oct;34(38):2949-3003.

JOURNAL:Eur Heart J. Article Link

2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology

Task Force Members, Montalescot G, Sechtem U et al. Keywords: Angina pectoris; Coronary revascularization; Guidelines; Myocardial ischaemia; Risk factors; Stable coronary artery disease; anti-ischaemic drugs

FULL TEXT PDF